These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease. Majumdar A; Tsochatzis EA Metabolism; 2020 Oct; 111S():154291. PubMed ID: 32531295 [TBL] [Abstract][Full Text] [Related]
11. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156 [TBL] [Abstract][Full Text] [Related]
12. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986 [TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management. Battistella S; D'Arcangelo F; Grasso M; Zanetto A; Gambato M; Germani G; Senzolo M; Russo FP; Burra P Clin Mol Hepatol; 2023 Feb; 29(Suppl):S286-S301. PubMed ID: 36577425 [TBL] [Abstract][Full Text] [Related]
14. Liver transplantation and non-alcoholic fatty liver disease. Zezos P; Renner EL World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437 [TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries. Holmer M; Melum E; Isoniemi H; Ericzon BG; Castedal M; Nordin A; Aagaard Schultz N; Rasmussen A; Line PD; Stål P; Bennet W; Hagström H Liver Int; 2018 Nov; 38(11):2082-2090. PubMed ID: 29630771 [TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. Chrysavgis L; Giannakodimos I; Diamantopoulou P; Cholongitas E World J Gastroenterol; 2022 Jan; 28(3):310-331. PubMed ID: 35110952 [TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288 [TBL] [Abstract][Full Text] [Related]
18. Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy. Ferrarese A; Battistella S; Germani G; Russo FP; Senzolo M; Gambato M; Vitale A; Cillo U; Burra P Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208613 [No Abstract] [Full Text] [Related]
19. How will NAFLD change the liver transplant landscape in the 2020s? Villeret F; Dumortier J; Erard-Poinsot D Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101759. PubMed ID: 34311133 [TBL] [Abstract][Full Text] [Related]
20. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. Degasperi E; Colombo M Lancet Gastroenterol Hepatol; 2016 Oct; 1(2):156-164. PubMed ID: 28404072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]